scholarly journals Author Correction: Early pregnancy ultrasound measurements and prediction of first trimester pregnancy loss: A logistic model

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Laura Detti ◽  
Ludwig Francillon ◽  
Mary E. Christiansen ◽  
Irene Peregrin-Alvarez ◽  
Patricia J. Goedecke ◽  
...  
Keyword(s):  
Early Pregnancy ◽  
Logistic Model ◽  
Pregnancy Loss ◽  
First Trimester ◽  
First Trimester Pregnancy ◽  
Trimester Pregnancy ◽  
Ultrasound Measurements

scholarly journals Early pregnancy ultrasound measurements and prediction of first trimester pregnancy loss: A logistic model

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Laura Detti ◽  
Ludwig Francillon ◽  
Mary E. Christiansen ◽  
Irene Peregrin-Alvarez ◽  
Patricia J. Goeske ◽  
...  
Keyword(s):  
Early Pregnancy ◽  
Logistic Model ◽  
Pregnancy Loss ◽  
First Trimester ◽  
First Trimester Pregnancy ◽  
Trimester Pregnancy ◽  
Ultrasound Measurements

scholarly journals Is There an Association Between Early Pregnancy Losses and Low 25-Hydroxy Vitamin D Levels?

2017 ◽  
Vol 1 (1) ◽  
pp. 1-5
Author(s):  
Lebriz Hale Aktun ◽  
Yeliz Aykanat ◽  
Oktay Olmuscelik
Keyword(s):  
Vitamin D ◽  
Early Pregnancy ◽  
Pregnancy Loss ◽  
First Trimester ◽  
Normal Pregnancy ◽  
First Trimester Pregnancy ◽  
Pregnancy History ◽  
Trimester Pregnancy ◽  
25 Hydroxy Vitamin D

Objective: Since the etiology of pregnancy losses during first trimester has not still been clear, we aim to analyze the relationship between vitamin D deficiency and early pregnancy losses. Patients and Methods: The study was conducted on 200 women. Plasma was collected from 100 nulliparous women with singleton at 7-10 weeks of gestation (50 with viable gestation and 50 with pregnancy loss) and 100 non-gravid reproductive age women (50 with a successful pregnancy history and 50 with one or more spontaneous first trimester pregnancy loss history). Serum 25 (OH) D and calcium levels were compared between groups. Results: The serum 25(OH) D levels for the groups turned out to be 47.64 ± 3.2 (95% CI: 44.4-50.8 ng/ml) for normal pregnancy group, 27.3 ± 1.2 (95% CI: 26.1-28.5 ng/ml) for the group of early pregnancy loss, 38.5 ± 5.1 (95% CI: 33.4-43.6 ng/ml) for the non gravid women with healthy pregnancy history and 11.6 ± 4.2 (95% CI: 7.9 - 15.6 ng/ml) for the non-gravid women with history of 1 or more first trimester pregnancy loss. There was a strong correlation between low 25(OH) D levels and early pregnancy loss (odds ratio (OR): 1.70, 95% CI: 1.2-2.3, p <0.001). The calcium levels were significantly lower in pregnancy loss group than normal pregnancy and non-gravid groups (p=0.005, p=0.033 respectively). Conclusions: Although our study is emphasized on role of vitamin D in early pregnancy it is not possible to recommend screening and supplementation of vitamin D in early pregnancy, as prognosis of pregnancies receiving supplementation and the incidence of pregnancy related complications in follow-up are not known. Well designed studies with long term follow up results needed. Keywords: 25 hydroxy vitamin D, Pregnancy loss, 25 (OH) D vitamin

scholarly journals SARS-CoV-2 in first trimester pregnancy: a cohort study

2020 ◽  
Author(s):  
N la Cour Freiesleben ◽  
P Egerup ◽  
K V R Hviid ◽  
E R Severinsen ◽  
A M Kolte ◽  
...  
Keyword(s):  
Cohort Study ◽  
Pregnant Women ◽  
Early Pregnancy ◽  
Pregnancy Loss ◽  
First Trimester ◽  
Nuchal Translucency ◽  
First Trimester Pregnancy ◽  
Trimester Pregnancy ◽  
Increased Risk ◽  
First Trimester Scan

Abstract STUDY QUESTION Does maternal infection with severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) in first trimester pregnancy have an impact on the fetal development as measured by nuchal translucency thickness and pregnancy loss? SUMMARY ANSWER Nuchal translucency thickness at the first trimester scan was not significantly different in pregnant women with versus without SARS-CoV-2 infection in early pregnancy and there was no significantly increased risk of pregnancy loss in women with SARS-CoV-2 infection in the first trimester. WHAT IS KNOWN ALREADY Pregnant women are more vulnerable to viral infections. Previous coronavirus epidemics have been associated with increased maternal morbidity, mortality and adverse obstetric outcomes. Currently, no evidence exists regarding possible effects of SARS-CoV-2 in first trimester pregnancies. STUDY DESIGN, SIZE, DURATION Cohort study of 1019 women with a double test taken between 17 February and 23 April 2020, as a part of the combined first trimester risk assessment, and 36 women with a first trimester pregnancy loss between 14 April and 21 May 2020, prior to the double test. The study period was during the first SARS-CoV-2 epidemic wave in Denmark. PARTICIPANTS/MATERIALS, SETTING, METHODS Cohort 1 included pregnant women with a double test taken within the study period. The excess serum from each double test was analyzed for SARS-CoV-2 antibodies. Results were correlated to the nuchal translucency thickness and the number of pregnancy losses before or at the time of the first trimester scan. Cohort 2 included women with a pregnancy loss before the gestational age for double test sample. Serum from a blood test taken the day the pregnancy loss was identified was analyzed for SARS-CoV-2 antibodies. The study was conducted at a public university hospital serving ∼12% of pregnant women and births in Denmark. All participants in the study provided written informed consent. MAIN RESULTS AND THE ROLE OF CHANCE Eighteen (1.8%) women had SARS-CoV-2 antibodies in the serum from the double test suggestive of SARS-CoV-2 infection in early pregnancy. There was no significant difference in nuchal translucency thickness for women testing positive for previous SARS-CoV-2 infection (n = 16) versus negative (n = 966) (P = 0.62). There was no significantly increased risk of pregnancy loss for women with antibodies (n = 1) (OR 3.4, 0.08–24.3 95% CI, P = 0.27). None of the women had been hospitalized due to SARS-CoV-2 infection. None of the women with pregnancy loss prior to the double test (Cohort 2) had SARS-CoV-2 antibodies. LIMITATIONS, REASONS FOR CAUTION These results may only apply to similar populations and to patients who do not require hospitalization due to SARS-CoV-2 infection. A limitation of the study is that only 1.8% of the study population had SARS-CoV-2 antibodies suggestive of previous infection. WIDER IMPLICATION OF THE FINDINGS Maternal SARS-CoV-2 infection had no effect on the nuchal translucency thickness and there was no significantly increased risk of pregnancy loss for women with SARS-CoV-2 infection in first trimester pregnancy. Evidence concerning COVID-19 in pregnancy is still limited. These data indicate that infection with SARS-CoV-2 in not hospitalized women does not pose a significant threat in first trimester pregnancies. Follow-up studies are needed to establish any risk to a fetus exposed to maternal SARS-CoV-2 infection. STUDY FUNDING/COMPETING INTEREST(S) Prof. H.S.N. and colleagues received a grant from the Danish Ministry of Research and Education for research of COVID-19 among pregnant women. The Danish government was not involved in the study design, data collection, analysis, interpretation of data, writing of the report or decision to submit the paper for publication. A.I., J.O.-L., J.B.-R., D.M.S., J.E.-F. and E.R.H. received funding from a Novo Nordisk Foundation (NNF) Young Investigator Grant (NNF15OC0016662) and a Danish National Science Foundation Center Grant (6110-00344B). A.I. received a Novo Scholarship. J.O.-L. is funded by an NNF Pregraduate Fellowship (NNF19OC0058982). D.W. is funded by the NNF (NNF18SA0034956, NNF14CC0001, NNF17OC0027594). A.M.K. is funded by a grant from the Rigshospitalet’s research fund. H.S.N. has received speaker’s fees from Ferring Pharmaceuticals, Merck Denmark A/S and Ibsa Nordic (outside the submitted work). N.l.C.F. has received a grant from Gedeon Richter (outside the submitted work). A.M.K. has received speaker’s fee from Merck (outside the submitted work). The other authors did not report any potential conflicts of interest. TRIAL REGISTRATION NUMBER N/A

scholarly journals Incidental Endometrial Carcinoma Diagnosed at First Trimester Pregnancy Loss: A Case Report

2014 ◽  
Vol 36 (11) ◽  
pp. 1010-1013 ◽  
Author(s):  
Lana Saciragic ◽  
Christopher G. Ball ◽  
Shahidul Islam ◽  
Michael Fung-Kee-Fung
Keyword(s):  
Case Report ◽  
Endometrial Carcinoma ◽  
Pregnancy Loss ◽  
First Trimester ◽  
First Trimester Pregnancy ◽  
Trimester Pregnancy

Extensive Thrombosis and First-Trimester Pregnancy Loss Caused by Sticky Platelet Syndrome

2011 ◽  
Vol 117 (2, Part 2) ◽  
pp. 501-503 ◽  
Author(s):  
Martha W. F. Rac ◽  
Natalie Minns Crawford ◽  
Kevin C. Worley
Keyword(s):  
Pregnancy Loss ◽  
First Trimester ◽  
First Trimester Pregnancy ◽  
Trimester Pregnancy

scholarly journals Adjuvant acupuncture reduces first trimester pregnancy loss after IVF

2012 ◽  
Vol 02 (03) ◽  
pp. 283-286 ◽  
Author(s):  
Naseem M. Khorram ◽  
Susan Horton ◽  
Vicken Sahakian ◽  
Richard Chacon ◽  
Omid Khorram
Keyword(s):  
Pregnancy Loss ◽  
First Trimester ◽  
First Trimester Pregnancy ◽  
Trimester Pregnancy

scholarly journals EMBRYONIC HEART RATE: A PROGNOSTIC FACTOR OF FIRST TRIMESTER PREGNANCY OUTCOME

2021 ◽  
Vol 5 (2) ◽  
Author(s):  
Chetana Choudhary ◽  
Lata Rajoria ◽  
Chelsae Kuntal ◽  
Sunita Hemani ◽  
Aditi Bansal ◽  
...  
Keyword(s):  
Heart Rate ◽  
Gestational Age ◽  
Pregnancy Loss ◽  
Cardiac Activity ◽  
First Trimester ◽  
Good Prognosis ◽  
Embryonic Heart ◽  
Transvaginal Sonography ◽  
First Trimester Pregnancy ◽  
Trimester Pregnancy

Introduction: The earliest proof of a viable pregnancy is obtained when cardiac activity of the embryo can be observed. Transvaginal sonography can accurately demonstrate embryonic heart rate at 6 weeks of gestational age by using M-mode transvaginal sonography. Slow embryonic heart rate at 6-7 weeks of gestational age is associated with high rate of first trimester pregnancy loss. AIM:  The study was aimed to evaluate the role of embryonic heart rate (EHR) of early pregnancies as predictive factor of adverse outcome at end of first trimester of pregnancy. Methods: This observational study was conducted in the Department of Obstetrics and Gynecology Zenana Hospital, SMS Medical College, Jaipur. It included 300 pregnant women between 6 weeks to 9 weeks of gestational age attending antenatal OPD. Embryonic heart rate was measured by transvaginal sonography. Embryonic heart rate was classified as slow, if it was fewer than 110 beats/ mint or outcome was measured as occurance of spontaneous pregnancy loss prior to 12 weeks. Results: Out of 300 cases, 290 (96.67%) had embryonic heart rate ?100 beats per minutes and 10(3.33%) had embryonic heart rate <100 beats per minutes. Out of these 290, (Embryonic heart rate ?100 beats per minutes), 284 (97.93%) had good prognosis and 6 (2.07%) had abortion. In 10 women (Embryonic heart rate <100 beats per minutes), 3 (30.00%) had good prognosis and 7 (70.00%) had abortion. This observation was statistically significant. Conclusion: Slow embryonic heart rate on ultrasonography reduced the success of pregnancy and may lead to abortion. Keywords: Embryonic heart rate, Ultrasonography, Early pregnancy loss

Sign in / Sign up

Export Citation Format

Share Document